MFQ-111, a novel human gtpase like protein

Details for Australian Patent Application No. 2001295458 (hide)

Owner Merck Patent GmbH

Inventors Piulats Xanco, Jaume; Masa Alvarez, Marc; Rosell-Vives, Elisabet; Masa Alvarez, Marc; Messenguer Peypoch, Ramon; Rodes Gubern, Blanca; Rosell Vives, Elisabet; Piulats Xanco, Jaume; Rodes Gubern, Blanca; Messeguer Peypoch, Ramon

Agent Davies Collison Cave

Pub. Number AU-B-2001295458

PCT Pub. Number WO02/16561

Priority 00117781.5 18.08.00 EP

Filing date 13 August 2001

Wipo publication date 4 March 2002

Acceptance publication date 25 January 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/42 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving phosphatase

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

25 January 2007 Application Accepted

  Published as AU-B-2001295458

24 May 2007 Standard Patent Sealed

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001295460

2001295457-Use of CARP inhibitors for the treatment of heart diseases